Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soe, G
Right arrow Articles by Matsuda, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soe, G
Right arrow Articles by Matsuda, M
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma

G Soe, I Kohno, K Inuzuka, Y Itoh and M Matsuda

Central Research Laboratories, Iatron Laboratories Inc, Chiba, Japan.

Using urea-solubilized human fibrin monomer as an immunogen, we raised in mice a battery of monoclonal antibodies that reacted with the immunogen but not with urea-treated or native fibrinogen. Although they all failed to react with acid-solubilized fibrin monomer (acid-FM) alone, an antibody designated as IF-43 was found to recognize acid-FM, which was bound with fibrinogen or its derivatives to form a 1:2 complex of soluble fibrin. The epitope for this antibody, thus, appears to be exposed most probably by conformation changes induced in the acid- FM molecule upon formation of the complex. Because IF-43 was able to recognize fibrin-derived plasmic fragment E treated with urea but not the thrombin- and urea-treated amino-terminal disulfide knot of fibrinogen, the presence of the A alpha (52-78) residue segment seems to be prerequiste for the epitope expression. The antibody was found to react with soluble fibrin monomer spiked to normal plasma dose- dependently up to 200 micrograms/mL. By an aggregation assay using latex beads coated with IF-43, we found that concentrations of soluble fibrin monomer in plasma derived from patients with thrombotic diseases were mostly elevated, but not necessarily correlated with those of the D-dimer, reflecting another aspects of the disease. Furthermore, the soluble fibrin monomer in plasma derived from patients with thrombotic diseases was found to be depleted solely of the A peptides, but not the B peptides, based on its subunit polypeptide compositions lacking the beta-chain on immunoblotting.

Volume 88, Issue 6, pp. 2109-2117, 09/15/1996
Copyright © 1996 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CLIN APPL THROMB HEMOSTHome page
S. Ota, H. Wada, Y. Abe, E. Yamada, A. Sakaguchi, J. Nishioka, T. Hatada, K. Ishikura, N. Yamada, A. Sudo, et al.
Elevated Levels of Prothrombin Fragment 1 + 2 Indicate High Risk of Thrombosis
Clinical and Applied Thrombosis/Hemostasis, July 1, 2008; 14(3): 279 - 285.
[Abstract] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
T. Matsumoto, H. Wada, T. Nobori, K. Nakatani, K. Onishi, M. Nishikawa, H. Shiku, Y. Kazahaya, T. Sawai, K. Koike, et al.
Elevated Plasma Levels of Fibrin Degradation Productsby Granulocyte-Derived Elastase in Patients with Disseminated Intravascular Coagulation
Clinical and Applied Thrombosis/Hemostasis, October 1, 2005; 11(4): 391 - 400.
[Abstract] [PDF]


Home page
Clin. Chem.Home page
A. Hamano, M. Umeda, Y. Ueno, S. Tanaka, J. Mimuro, and Y. Sakata
Latex Immunoturbidimetric Assay for Soluble Fibrin Complex
Clin. Chem., January 1, 2005; 51(1): 183 - 188.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
H. Wada, T. Sase, T. Matsumoto, F. Kushiya, M. Sakakura, Y. Mori, M. Nishikawa, K. Ohnishi, K. Nakatani, E. C. Gabazza, et al.
Increased Soluble Fibrin in Plasma of Patients with Disseminated Intravascular Coagulation
Clinical and Applied Thrombosis/Hemostasis, July 1, 2003; 9(3): 233 - 240.
[Abstract] [PDF]


Home page
BloodHome page
I. Kohno, K. Inuzuka, Y. Itoh, K. Nakahara, Y. Eguchi, T. Sugo, G. Soe, Y. Sakata, H. Murayama, and M. Matsuda
A monoclonal antibody specific to the granulocyte-derived elastase-fragment D species of human fibrinogen and fibrin: its application to the measurement of granulocyte-derived elastase digests in plasma
Blood, March 1, 2000; 95(5): 1721 - 1728.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1996 by American Society of Hematology         Online ISSN: 1528-0020